130 related articles for article (PubMed ID: 31122953)
1. Death by antibody.
Faccini T; Dhesi Z; Shah S
BMJ Case Rep; 2019 May; 12(5):. PubMed ID: 31122953
[TBL] [Abstract][Full Text] [Related]
2. Sarcoidosis manifesting during treatment with secukinumab for psoriatic arthritis.
Kirby C; Herlihy D; Clarke L; Mullan R
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33619146
[TBL] [Abstract][Full Text] [Related]
3. Veno-veno-arterial extracorporeal membrane oxygenation for acute respiratory distress syndrome with septic-induced cardiomyopathy due to severe pulmonary tuberculosis.
Lee SI; Hwang HJ; Lee SY; Choi CH; Park CH; Park KY; Kim YJ
J Artif Organs; 2017 Dec; 20(4):359-364. PubMed ID: 28864904
[TBL] [Abstract][Full Text] [Related]
4. The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?
Rodríguez Moncada R; Vázquez Morón JM; Pallarés Manrique H
Rev Esp Enferm Dig; 2019 Sep; 111(9):720-721. PubMed ID: 31333036
[TBL] [Abstract][Full Text] [Related]
5. Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis.
Toussirot E
Expert Opin Biol Ther; 2018 Jan; 18(1):101-107. PubMed ID: 29187009
[TBL] [Abstract][Full Text] [Related]
6. Successful use of extracorporeal membrane oxygenation support in severe septic shock with associated acute cardiomyopathy.
Perdue SM; Poore BJ; Babu AN; Stribling WK
J Card Surg; 2018 Jan; 33(1):50-52. PubMed ID: 29314296
[TBL] [Abstract][Full Text] [Related]
7. [Sepsis-induced cardiomyopathy complicated with cardiogenic shock patients supported with extracorporeal membrane oxygenation].
Liu C; Zhu R; Zhou Z; Liu H; Lin J; Wen S; Zuo L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Dec; 29(12):1140-1143. PubMed ID: 29216952
[TBL] [Abstract][Full Text] [Related]
8. Secukinumab: IL-17A inhibition to treat psoriatic arthritis.
Speeckaert R; van Geel N; Lambert J; Claeys L; Delanghe JR; Speeckaert MM
Drugs Today (Barc); 2016 Nov; 52(11):607-616. PubMed ID: 28112279
[TBL] [Abstract][Full Text] [Related]
9. Candida glabrata vertebral osteomyelitis in an immunosuppressed patient.
Tan AC; Parker N; Arnold M
Int J Rheum Dis; 2014 Feb; 17(2):229-31. PubMed ID: 24576284
[No Abstract] [Full Text] [Related]
10. Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis.
Mease PJ; McInnes IB; Kirkham B; Kavanaugh A; Rahman P; van der Heijde D; Landewé R; Nash P; Pricop L; Yuan J; Richards HB; Mpofu S;
N Engl J Med; 2015 Oct; 373(14):1329-39. PubMed ID: 26422723
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.
Canavan TN; Elmets CA; Cantrell WL; Evans JM; Elewski BE
Am J Clin Dermatol; 2016 Feb; 17(1):33-47. PubMed ID: 26649440
[TBL] [Abstract][Full Text] [Related]
12. Candida glabrata-Induced Refractory Infectious Arthritis: A Case Report and Literature Review.
Chen S; Chen Y; Zhou YQ; Liu N; Zhou R; Peng JH; Qian QR
Mycopathologia; 2019 Apr; 184(2):283-293. PubMed ID: 30903581
[TBL] [Abstract][Full Text] [Related]
13. An urgent open surgical approach for left ventricle venting during peripheral veno-arterial extracorporeal membrane oxygenation for refractory cardiac arrest: case report.
Beyls C; Huette P; Guilbart M; Nzonzuma A; Abou Arab O; Mahjoub Y
Perfusion; 2020 Jan; 35(1):82-85. PubMed ID: 31218916
[TBL] [Abstract][Full Text] [Related]
14. A Case of Oral Candidiasis Caused by Candida dubliniensis During Treatment of Humanized Monoclonal Antibody to Interleukin-17A.
Takeda K; Futatsuya T; Anzawa K; Mochizuki T; Shimizu A; Yamada K
Med Mycol J; 2022; 63(4):87-90. PubMed ID: 36450567
[TBL] [Abstract][Full Text] [Related]
15. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial.
McInnes IB; Behrens F; Mease PJ; Kavanaugh A; Ritchlin C; Nash P; Masmitja JG; Goupille P; Korotaeva T; Gottlieb AB; Martin R; Ding K; Pellet P; Mpofu S; Pricop L;
Lancet; 2020 May; 395(10235):1496-1505. PubMed ID: 32386593
[TBL] [Abstract][Full Text] [Related]
16. Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.
Glatt S; Baeten D; Baker T; Griffiths M; Ionescu L; Lawson ADG; Maroof A; Oliver R; Popa S; Strimenopoulou F; Vajjah P; Watling MIL; Yeremenko N; Miossec P; Shaw S
Ann Rheum Dis; 2018 Apr; 77(4):523-532. PubMed ID: 29275332
[TBL] [Abstract][Full Text] [Related]
17. Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis.
Commons RJ; Grivas R; Currie BJ
Intern Med J; 2014 Dec; 44(12a):1245-6. PubMed ID: 25442759
[TBL] [Abstract][Full Text] [Related]
18. Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report.
Lu J; Tang S; Yu N; Yi X; Li Y
J Int Med Res; 2020 Nov; 48(11):300060520969494. PubMed ID: 33161790
[TBL] [Abstract][Full Text] [Related]
19. Successful use of extracorporeal membrane oxygenation for pulmonary embolism, prolonged cardiac arrest, post-partum: a cannulation dilemma.
Fernandes P; Allen P; Valdis M; Guo L
Perfusion; 2015 Mar; 30(2):106-10. PubMed ID: 25304130
[TBL] [Abstract][Full Text] [Related]
20. Veno-arterial extracorporeal membrane oxygenation for Streptococcus pyogenes toxic shock syndrome in pregnancy.
Imaeda T; Nakada TA; Abe R; Tateishi Y; Oda S
J Artif Organs; 2016 Jun; 19(2):200-3. PubMed ID: 26758056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
